- Home
- NKTR vs NN Comparison
NKTR vs NN Comparison
Compare NKTR & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTR | NN |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NKTR | NN |
|---|---|---|
| Price | $37.24 | $8.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $133.08 | $33.67 |
| AVG Volume (30 Days) | 599.5K | ★ 3.4M |
| Earning Date | 11-12-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $307,711,000.00 | $4,573,000.00 |
| Revenue This Year | N/A | $9.63 |
| Revenue Next Year | $27.72 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 86.00 | N/A |
| 52 Week Low | $33.40 | $7.60 |
| 52 Week High | $109.00 | $24.42 |
Technical Indicators
Market Signals| Indicator | NKTR | NN |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 38.23 |
| Support Level | $35.68 | $7.60 |
| Resistance Level | $40.12 | $17.92 |
| Average True Range (ATR) | 1.55 | 1.23 |
| MACD | 0.90 | -0.05 |
| Stochastic Oscillator | 37.77 | 21.56 |
Price Performance
Historical ComparisonAbout NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
About NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system delivers resilient, next-generation, complementary positioning, navigation, and timing (PNT) solutions designed to overcome the limitations and vulnerabilities of existing space-based Global Navigation Satellite Systems (GNSS), including the Global Positioning System (GPS). The products of the company include NextNav Pinnacle: Accurate vertical location, NextNav 3D: 3D location visualization, NextNav TerraPoiNT: Resilient PNT for 3D and indoor geolocation, Next Generation Solution: Terrestrial 3D PNT powered by spectrum.